Journals / İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası / 2004 / Cilt: 67 - Sayı: 4

The effect of losartan on the plasma level of prolactin, thyrotropin (TSH), and cortisol in patients with mild and moderate essential hypertension

Hafif ve orta derecede esansiyel hipertansiyonu olan hastalarda losartan'ın plazma prolaktin, kortizol ve TSH düzeylerine etkisi

Pages
224–228
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Student-t test and chi-square test were used for statistical evaluation of quantitative and qualitative values, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The effect of losartan on the plasma level of prolactin, thyrotropin (TSH), and cortisol in patients with mild and moderate essential hypertension.
📊
Key Findings & Data:In this study, we aimed to investigate serum levels of prolactin, thyrotropin (TSH) and cortisol in patients having mild and moderate hypertension, to compare with healty subjects, and to investigate changes -of levels of these hormones after treatment with losartan, which is an angiotensin receptor blocker. 40 mild and moderate hypertensive patients (24 women, mean age; 51.2+8.7 years) followed in our center and 20 healthy subjects (7 women, mean age; 50.1±14.6 years) as a control group were inclu¬ded in this study.
💡
Conclusion & Impact:Student-t test and chi-square test were used for statistical evaluation of quantitative and qualitative values, respectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The effect of losartan on the plasma level of prolactin, thyrotropin (TSH), and cortisol in patients with mild and moderate essential hypertension. In this study, we aimed to investigate serum levels of prolactin, thyrotropin (TSH) and cortisol in patients having mild and moderate hypertension, to compare with healty subjects, and to investigate changes -of levels of these hormones after treatment with losartan, which is an angiotensin receptor blocker. 40 mild and moderate hypertensive patients (24 women, mean age; 51.2+8.7 years) followed in our center and 20 healthy subjects (7 women, mean age; 50.1±14.6 years) as a control group were inclu¬ded in this study. Blood pressure of the patients were measured in the sitting position in accordance with "The Sixth Joint National Committee" report10. Serum prolactin, cortisol and TSH levels were measured by Kodak VITROS ECI Immunodiagnostic machine and Chemiluminescent Immunoassay method. SPSS 10 software was used for statistical evaluation of the data. Student-t test and chi-square test were used for statistical evaluation of quantitative and qualitative values, respectively. P

Özet

Bu çalışmada hafif ve orta derecede hipertansiyonu olan hastalarda serum prolaktin, tirotropin (TSH) ve kortizol düzeylerinin araştırılması, sağlıklı kişilerle karşılaştırılması ve anjiyotensin reseptor blokeri olan losartan ile yapılan tedaviden sonra bu hormonlann serum düzeylerinde meydana gelebilecek değişikliklerin araştırılması amaçlanmıştır. Çalışma kapsamına merkezimizde hafif ve orta derecede hipertansiyon nedeniyle takip edilen 40 hasta (24 kadin, ortalama yaş; 51.2+8.7 yıl) ve kontrol grubu olarak 20 sağlıklı (7 kadin, ortalama yaş;50.1+14.6 yil) kişi alınmıştır.Hastalarin kan basıncı ölçümleri "The Sixth Joint National Committee" raporunda belirtilen standartlara uygun olarak oturur durumda ölçüldü.Prolaktin, kortizol ve TSH tetkikleri ise Kodak VITROS ECI Immündiagnostik cihazi ve Chemiluminescent Immiinassay yontemi ile yapıldı. Verilerin istatistiki degerlendirmesi için SPSS 10 programı kullanilmiştir. Kantitatif'değerlerin istatistiki karşılaştırılması amacıyla Student-t testi, kalitatif degerler için de ki-kare testi kullanıdi. P

🔖

Cite This Article

OFLAZ, H., KOYLAN, N., TOPBAŞ, A., BİLGE, A. K., SOYLUK, Ö., BİRİCİK, F. S., KOCAMAN, O. (2022). The effect of losartan on the plasma level of prolactin, thyrotropin (TSH), and cortisol in patients with mild and moderate essential hypertension. İstanbul Üniversitesi İstanbul Tıp Fakültesi Mecmuası, Cilt: 67 - Sayı: 4, 224–228. https://ajindex.com/articles/553666

References (15)

  1. Brenner BM and Anderson S: The interrelationships among filtration surface area, blood pressure and chronic renal disease. J Cardiovasc Pharmacol 1992; 19:1
  2. Culman J, Hohle S, Qadri F, Edling O, Blume A, Lebrun C, Unger T: Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis. Clin Exp Hypertens 1995; 17:281
  3. Denolle T, Rohmer V, Saint-Adnre JP, Guyene TT, Galland F, Bigorgne JC, Schambelan M, Corvol P: Effect of the circulating renin-angiotensin system on prolactin release in human. J Clin Endocrinol Metab 1990;70: 288
  4. Doyle AE, Fraser JRE: Vascular reactivity in hypertension. Circ Res 1961;9:755
  5. Eryılmaz Y: Hipertansiyon Etyopatogenezinde Merkezi Sinir Sistemi ve RAS.A 11 Konseyi bülteni 1997, No:3
  6. Floras JS and Hara K: Sympathoneural and hemodynamic characteristics of young subjects with mild essential hypertension. J. Hypertens 1993; 11:647
  7. Guyton AC: Kidneys arçd fuidş in pressure regulation: Small volume but large pressure changes. Hypertension 1992; 19:1
  8. Hunt SC, Hopkins PN and Williams RR: Hypertension:Genetics mechanisms. In Fuster V, Ross R and Topol EJ:(eds):Atherosclerosis and Coronary Artery disease. Philedelphia, Lippincott-Raven Publishers, 1996, p:209
  9. Janik JM, Robinson Q, Shen J, Callahan P: Effects of age and gender on the A 11-induced stimulation of prolactin release and inositol phosphate accumulation in rat anterior pituitary cells in vitro. Mech-Ageing-Dev 1997; 95:113
  10. Kaplan, NM.:Clinical hypertension. 7 th ed. Baltimore, by Williams and Wilkins, 1998, p:9,12,45,67
  11. Law CM, Shiell. Is blood pressure inversly related to birth weight.The stregth of evidence from a systematic rewiew of the literature. J Hypertens 1996; 4:935
  12. Lombardi C, Missale C, Poli M, De Cotiis R, Memo M, Spedini C, Spano PF: Regulation mechanism in prolaction secretion possible role of the hypophyseal renin-anjiotensin system. Minerva-Med 1990; 81:587
  13. Maheux P, Jeppesen J, Sheu WH, Hollenbeck CB, Clinkingbeard C, Greenfield MS, Chen YD, Reaven GM: Additive effects of obesty, hypertension, and type 2 diabetes on insulin resistance. Hypertension 1994; 24:695
  14. Miiller R, Steffen HM, Weller P and Krone W: Plasma catecholamines and adrenoreceptors in young hypertensive patients. J. Hum.Hypertens 1994; 8:351
  15. Smith S, Julius S, Jamerson K, Amerena J, Schork N: Hematocrits levels and physiologic factors in relationship to cardiovasculer risk in Tecumseh. Mich